SCREW,FIXATION,BONE
Report
- Report Number
- 8030965-2019-63659
- Event Type
- Injury
- Date Received
- May 8, 2019
- Date of Event
- September 29, 2014
- Report Date
- April 10, 2019
- Manufacturer
- OBERDORF SYNTHES PRODUKTIONS GMBH
- Product Code
- HWC
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CH
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
(B)(6) THIS REPORT IS FOR UNKNOWN SCREWS. PART#, LOT# AND UDI # IS NOT AVAILABLE. DEVICE IS NOT EXPECTED TO BE RETURNED FOR MANUFACTURER REVIEW/INVESTIGATION. THIS REPORT IS FOR UNKNOWN SCREWS. PMA/510(K) NUMBER IS NOT AVAILABLE. PRODUCT WAS NOT RETURNED. DEVICE HISTORY RECORDS REVIEW COULD NOT BE COMPLETED WITHOUT LOT NUMBER. BASED ON THE INFORMATION AVAILABLE, IT HAS BEEN DETERMINED THAT NO CORRECTIVE AND PREVENTATIVE ACTION IS PROPOSED. THIS COMPLAINT WILL BE ACCOUNTED FOR AND MONITORED VIA POST MARKET SURVEILLANCE ACTIVITIES. IF ADDITIONAL INFORMATION IS MADE AVAILABLE, THE INVESTIGATION WILL BE UPDATED AS APPLICABLE. DEVICE WAS USED FOR TREATMENT, NOT DIAGNOSIS. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. (B)(4).
THIS REPORT IS BEING FILED AFTER THE REVIEW OF THE FOLLOWING JOURNAL ARTICLE: FEI, W. ET AL (2014), FREE VASCULARIZED MEDIAL FEMORAL CONDYLE CORTICOCANCELLOUS FLAP FOR TREATMENT OF CHALLENGING UPPER EXTREMITY NONUNIONS, JOURNAL OF RECONSTRUCTIVE MICROSURGERY, VOL. 31, NO. 2, PAGES 124-131 (CHINA). THE AIM OF THIS STUDY IS TO DETERMINE THE EFFECTIVITY OF FREE VASCULARIZED MFC CORTICOCANCELLOUS FLAP TO PATIENTS WITH CHALLENGING UPPER EXTREMITY NONUNIONS AND SMALL BONE DEFECTS. BETWEEN JANUARY 2012 TO DECEMBER 2013, A TOTAL OF 15 PATIENTS (12 MALE AND 3 FEMALE) WITH A MEAN AGE OF 35 YEARS (RANGE 18-56 YEARS) WERE INCLUDED IN THIS STUDY. THERE WERE 12 ATROPHIC NONUNIONS AND 3 HYPERTROPHIC NONUNIONS. THE MEAN TIME FROM FRACTURE TO THE FREE MFC FLAP RECONSTRUCTION WAS 10 MONTHS (RANGE, 8¿15 MONTHS). THE MEAN NUMBER OF PREVIOUS PROCEDURES WAS 1.5 (RANGE, 0¿3) INCLUDING THE USE OF BONE GRAFTING (AUTOGRAFT/ALLOGRAFT), BONE STIMULATOR (ELECTRIC STIMULATION/ ULTRASOUND), AND GROWTH FACTOR INJECTION. ALL 13 PATIENTS WENT ON TO BONY UNION AT AN AVERAGE OF 15 WEEKS (RANGE, 8¿22 WEEKS) (TABLE 1 AND FIGS. 5¿9). THE MEAN FOLLOW-UP AFTER FREE MFC RECONSTRUCTION WAS 12 MONTHS (RANGE 4-19 MONTHS). THE FOLLOWING COMPLICATIONS WERE REPORTED AS FOLLOWS: A (B)(6) YEAR-OLD MALE (PATIENT 1) HAD A 5 DEGREE LIMITATION OF ACTIVE SUPINATION AND 15 DEGREE LIMITATION OF ACTIVE PRONATION. 1 PATIENT DEVELOPED A HEMATOMA AT THE FLAP DONOR SITE. THIS REPORT IS FOR UNKNOWN SCREWS. IT CAPTURES 1 PATIENT DEVELOPED A HEMATOMA AT THE FLAP DONOR SITE. THIS IS REPORT 2 OF 2 FOR (B)(4).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 383016 | SCREW,FIXATION,BONE | HWC | OBERDORF SYNTHES PRODUKTIONS GMBH |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |